Evidence that cytochrome P-4502E1 contributes to ethanol elimination at low doses: effects of diallyl sulfide and 4-methyl pyrazole on ethanol elimination in the perfused rat liver

Alcohol Clin Exp Res. 1996 Feb;20(1 Suppl):12A-16A. doi: 10.1111/j.1530-0277.1996.tb01719.x.

Abstract

The roles of cytochrome P-4502E1 and alcohol dehydrogenase (ADH) on ethanol (EtOH) hepatic elimination was examined in the perfused rat liver. EtOH concentration-time curves of outflow after instantaneous administration (0.46 mg) through the portal vein with or without perfusion of diallyl sulfide (DAS), a selective cytochrome P-450E1 inhibitor, and/or 4-methyl pyrazole (4-MP), a classical ADH inhibitor, were analyzed by the statistical moment analysis and the compartment dispersion model. Recovery ratios obtained by moment analysis significantly changed with perfusion of inhibitors (p < 0.01). Values of the hepatic volume of distribution and the relative dispersion were significantly higher by the perfusion of DAS and 4-MP (p < 0.01). In the two-compartment dispersion model, the partition ratio (K') and the first-order elimination constant (K0) were decreased significantly by DAS (p < 0.05). By the addition of 4-MP, the blood volume of distribution (VB) and the backward partition rate constant (k21) were increased significantly (p < 0.05). K sigma values were decreased significantly to 0 (p < 0.001). The decrease of elimination rates by DAS and/or 4-MP shows the inhibition of metabolic pathways. The change of V beta and k21 caused by DAS and 4-MP indicates that EtOH taken into hepatic tissues was not metabolized and flowed out into the perfusates. Inhibition rates calculated from the efficiency number with addition of DAS and DAS + 4-MP were 40.7 and 99.3%. Therefore, cytochrome P-4502E1 and ADH accounted for 40 and 60% of the hepatic EtOH elimination at low doses.

MeSH terms

  • Alcohol Dehydrogenase / antagonists & inhibitors*
  • Alcohol Dehydrogenase / physiology
  • Allyl Compounds*
  • Animals
  • Cytochrome P-450 CYP2E1
  • Cytochrome P-450 Enzyme Inhibitors*
  • Cytochrome P-450 Enzyme System / physiology
  • Dose-Response Relationship, Drug
  • Ethanol / pharmacokinetics*
  • Fomepizole
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Metabolic Clearance Rate / drug effects
  • Metabolic Clearance Rate / physiology
  • Models, Theoretical
  • Oxidoreductases, N-Demethylating / antagonists & inhibitors*
  • Oxidoreductases, N-Demethylating / physiology
  • Perfusion
  • Pyrazoles / pharmacology*
  • Rats
  • Rats, Wistar
  • Sulfides / pharmacology*

Substances

  • Allyl Compounds
  • Cytochrome P-450 Enzyme Inhibitors
  • Pyrazoles
  • Sulfides
  • Ethanol
  • allyl sulfide
  • Fomepizole
  • Cytochrome P-450 Enzyme System
  • Alcohol Dehydrogenase
  • Cytochrome P-450 CYP2E1
  • Oxidoreductases, N-Demethylating